Results 81 to 90 of about 4,823 (126)
Some of the next articles are maybe not open access.

IMIPENEM-CILASTATIN

Obstetrics and Gynecology Clinics of North America, 1992
Imipenem-cilastatin, with its broad spectrum of activity and relative safety, offers an excellent alternative for the treatment of many obstetric and gynecologic infections. In addition, the possibilities for intramuscular administration give clinicians additional treatment options.
openaire   +2 more sources

Imipenem-cilastatin and imipenem-relebactam

2017
The carbapenems are a group of bicyclic beta-lactam compounds with a common carbapenem nucleus. Imipenem (N-formimidoyl-thienamycin: C12H17N3O4S; average molecular weight: 299.3460) is one of these, and it has substantial activity against both aerobic and anaerobic bacteria, including many (but not all) beta-lactamase-producing strains.
Hayashi, Yoshiro, Paterson, David L.
openaire   +2 more sources

Pharmacology of imipenem

Journal of Antimicrobial Chemotherapy, 1985
M R, Lockley, R, Wise
openaire   +2 more sources

Imipenem Overprescribing

JAMA: The Journal of the American Medical Association, 1988
openaire   +2 more sources

Activities of imipenem-relebactam combination against carbapenem-nonsusceptible Enterobacteriaceae in Taiwan

Journal of Microbiology, Immunology and Infection, 2022
Tsung-Ying Yang   +2 more
exaly  

Imipenem/Cilastatin

European Journal of Clinical Microbiology, 1984
openaire   +2 more sources

Imipenem

Reactions Weekly, 1995
openaire   +2 more sources

Home - About - Disclaimer - Privacy